Gland Pharma shares fall over 4% after weak Q3 result, Jefferies target price cutGland Pharma share price: Revenue from operations fell 10% year-on-year to Rs 1,384 crore. EBITDA increased by 1% year-on-year to Rs 360 cr...
04 Feb, 2025, 09.53 AM IST
Gland Pharma Q3 net profit rises 7% to Rs 205 croreGland Pharma on Monday reported 7% year-on-year (YoY) rise in net profit to Rs 205 crores in Q3FY25.
03 Feb, 2025, 09.18 PM IST
Stocks in news: Wipro, Kotak Bank, Zomato, Motilal Oswal, Adani EnergyIT services company Wipro reported 24% growth in its consolidated net profit at Rs 3,354 crore, while revenue from operations rose by a mar...
20 Jan, 2025, 06.14 AM IST
Stocks in news: Nestle India, Titan, Vodafone Idea, Wipro, Tata SteelThe Board of Nestle India approved paying a royalty fee to its parent company Nestle S.A. The payment will be made at a rate of up to 5.25%...
08 Apr, 2024, 07.03 AM IST
Next big delta in pharma to come from biosimilars: Nithya Balasubramanian“For Aurobindo Pharma, our official rating is market performance. We do not recommend it from a long-term perspective. It is only a tactica...
28 Jun, 2023, 01.30 PM IST
Stocks in news: HDFC Life, SBI, LTI Mindtree, Gland Pharma, VedantaForeign entity WWD Ruby Ltd has offloaded its entire 4.77% stake in Sapphire Foods India Ltd through the open market on Tuesday for Rs 417 ...
28 Jun, 2023, 07.21 AM IST
Gland Pharma's Hyderabad unit gets one observation from USFDA after inspection"This observation is procedural in nature and the corrective and preventive actions for this observation will be submitted to the USFDA wit...
27 Jun, 2023, 08.54 PM IST
Nithya Balasubramanian on 2 pharma names to bet on besides Sun & Cipla“Coming to the complex generics opportunity, Cipla and Lupin are most exposed. We like Cipla more than Lupin because at least in the near t...
05 Jan, 2023, 02.42 PM IST
As Covid sales spike ebbs, what lies ahead for pharma companies?Indian pharmaceutical market flattened after the pandemic led to a massive upsurge in demand for drugs. The industry saw a rise in sales du...
12 Jul, 2022, 01.18 PM IST
Sun, Cipla, Gland Pharma should do well in FY23: Nithya Balasubramanian"Sun Pharma shifted focus from generics to speciality, which seems to be doing well. Relatively they have a portfolio that is immune from p...
09 Dec, 2021, 02.36 PM IST
Stock market watch: What to expect from the week ending October 15, 2021“A convincing weekly close and bottom base moving up 17,400 to 17,630 are good signs and they hint that Nifty may go up to 18,300-400 in co...
11 Oct, 2021, 06.30 AM IST
6 pharma stocks to bet on amid Covid 2.0"The private market has opened up for vaccination and Dr Reddy’s is likely to benefit from the sale of Sputnik-V vaccine."
06 May, 2021, 02.43 PM IST
Pharma stocks that will ride out the Covid disruption well into next yearVaccines to combat the pandemic and a thrust on diagnostics are near-term drivers. An uptick in acute drugs and business as usual at hospit...
23 Dec, 2020, 06.09 PM IST
Why investors need to be overweight on pharmaI remain very positive on pharma. Top pick still remains Aurobindo Pharma, says Dipan Mehta.
12 Nov, 2020, 11.39 AM IST
USFDA nods to Indian drugs up 84% in 1 yearInterestingly, the growth came during the period when biggies like Sun Pharma and Dr Reddy's had reduced filings from their plants due to c...
28 Jun, 2016, 09.47 AM IST
Torrent Pharma in talks to buy Glochem Industries for Rs 300 croreGlochem is a medium-sized company that makes bulk drugs, or active ingredients, which are used as raw material for medicines.
27 May, 2016, 05.11 AM IST
Baxter emerges as frontrunner to buy KKR-backed Gland Pharma for $1.1-1.2 billionHyderabad-headquartered Gland is a leading contract manufacturers of injectables, supplying to pharma majors in India and US like Dr Reddy’...
12 May, 2016, 06.49 AM IST